Dr Reddy's Labs gets USFDA nod for Omeprazole Mg OTC

MUMBAI: Drug manufacturer Dr Reddy���s Laboratories on Wednesday said it has received US regulatory approval for anti-heartburn capsules.

The company has received US Food and Drug Administration approval for its Abbreviated New Drug Application for Omeprazole Mg OTC, Dr Reddy���s Laboratories said in a filing to the Bombay Stock Exchange.

Omeprazole Mg OTC is indicated for the treatment of heartburn. Dr Reddy���s formulation contains 20.6 mg Omeprazole Mg and the dosage form is a capsule, the filing added.